Following over a year of slow uptake, Vertex Pharmaceuticals and CRISPR Therapeutics expect Casgevy revenues to nearly triple ...

Vertex Pharmaceuticals is downgraded to Hold ahead of Q4 earnings due to underwhelming growth from key new drugs. Click for this earnings preview of VRTX stock.

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

In early February 2026, WuXi Biologics announced a license and research service agreement granting Vertex Pharmaceuticals exclusive global rights to develop and commercialize a preclinical trispecific ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Minerals has outlined a series of steps designed to ramp up the Reward mine in New South Wales to ... Read More The post Vertex moves to accelerate ramp-up at Reward gold mine appeared first on ...

Redefine modern interiors with Vertex Flooring’s advanced SPC collection, durable, waterproof, and stylish flooring ...

Event context and recent share performance Vertex Pharmaceuticals (VRTX) has recently drawn investor attention without a single clear news catalyst, as the stock shows a month return of about 1.5% and ...

The platform has been adopted by leading production houses, including Vertex CGI and Secret Level, the AI-native studio behind campaigns for Coca-Cola, Will.i.am, and The Black Eyed Peas. Their Secret ...

Google's Nano Banana 2 brings Pro-level world knowledge at Flash speed, with impressive text handling and subject consistency ...

CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...